Novartis Oncology is committed to raising awareness and educating the healthcare community about the consequences of iron overload and the importance of early diagnosis and management.
On-Demand Professional Education
Dr. Paul Swerdlow and Dr. Richard A. Drachtman review the use of transfusion therapy as treatment for sickle cell disease.
Paul Swerdlow, MD
Director of Red Cell Disorders
Barbara Ann Karmanos Cancer Institute
Associate Professor
Wayne State University
Detroit, Michigan
Barbara Ann Karmanos Cancer Institute
Associate Professor
Wayne State University
Detroit, Michigan
Richard A. Drachtman, MD
Interim Chief, Pediatric
Hematology/Oncology Division
The Cancer Institute of New Jersey
Professor of Pediatrics
University of Medicine and Dentistry
of New Jersey
Robert Wood Johnson Medical School
New Brunswick, New Jersey
Hematology/Oncology Division
The Cancer Institute of New Jersey
Professor of Pediatrics
University of Medicine and Dentistry
of New Jersey
Robert Wood Johnson Medical School
New Brunswick, New Jersey
Professionals discuss iron overload in live, online webcasts. Find out about the latest news and developments by registering to participate in these scheduled events.
These downloadable videos present in-depth information for professionals about iron metabolism and iron overload. Some materials can be used to help patients understand the threat of iron overload and the importance of managing the condition.
Email
Print
About Novartis Oncology
Our primary goal is to research and develop new methods to treat cancer better than is possible today.
Learn more